Key result
Qualitative interviews reveal substantial barriers to understanding and monitoring cardiovascular toxicity in breast cancer patients.
Why the study?
Women with breast cancer face challenges in recognizing and managing potential cardiovascular toxicity during and after treatment, with gaps in awareness and healthcare communication.
Women with breast cancer face substantial barriers to understanding and monitoring for potential cardiovascular toxicity, highlighting a need for tailored education and proactive, patient-centered interventions.
Patient insights on CV toxicity self-management in breast cancer are hypothesis-generating; leaves open tailored surveillance integration.
Objective This study aimed to explore how women with breast cancer perceived potential cardiovascular toxicity and engaged in self-management to support their cardiovascular health, monitor for symptoms, and adhere to clinical surveillance. Methods A qualitative descriptive design was employed. Semi-structured interviews were conducted with a purposively selected sample of 12 women with breast cancer. The interviews were audio-recorded with the participants' consent and transcribed verbatim. NVivo 12 was used to organise the data, which were analysed using inductive thematic analysis to develop themes and subthemes. Results The study included 12 women aged 40–74 years. Participants reported multiple challenges in recognising and understanding potential cardiovascular toxicity, possible cardiovascular symptoms, and other treatment-related symptoms. Four themes and nine subthemes were identified: (1) overwhelming physical and functional burden of treatment; (2) fragmented knowledge and awareness of potential cardiovascular toxicity; (3) healthcare communication gaps and unmet informational needs; and (4) psychosocial and systemic barriers to overall well-being and health management. Conclusions The participants faced substantial barriers to understanding and monitoring for potential cardiovascular toxicity. These challenges highlight the need for the future development and evaluation of more proactive, patient-centred interventions. Proposed strategies, such as tailored education, symptom-reporting tools, and structured follow-up models, require future research to determine their effectiveness.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Breast cancer (n=12). Awareness of potential cardiovascular toxicity was evaluated on Perception of cardiovascular toxicity and barriers to self-management. Qualitative interviews with 12 women with breast cancer identified 4 themes highlighting substantial barriers to understanding and monitoring for potential cardiovascular toxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: